Ochsenreither, Sebastian
University of Liverpool · University Hospital Heidelberg · Princess Margaret Cancer Centre · Clatterbridge Cancer Centre NHS Foundation Trust · Mount Vernon Cancer Centre · National Center for Tumor Diseases · Stiftung Charité · Charité – Universitätsmedizin Berlin
2 papers on CoChatORCID 0000-0001-6024-4312
Most cited papers
- Verified
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Nathan, P., Hassel, J. C., Rutkowski, P., Baurain, J.-F., Butler, M. O., Schlaak, M., Sullivan, R. J., Ochsenreither, S., Dummer, R., Kirkwood, J. M., et al. (2021) · New England Journal of Medicine
Ocular Oncology and TreatmentsOcular Diseases and Behçet’s Syndrome
Cited by 924
- Verified
KRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma
Frost, N., Kollmeier, J., Vollbrecht, C., Grah, C., Matthes, B., Pultermann, D., von Laffert, M., Lüders, H., Olive, E., Raspe, M., et al. (2021) · Translational Lung Cancer Research
Lung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers
Cited by 61
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free